Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018 Article Swipe
Tessa du Toit
,
Tonya M. Esterhuizen
,
Nicki Tiffin
,
Ahmed A. Abulfathi
,
Helmuth Reuter
,
Eric Decloedt
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1186/s12879-020-05624-0
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1186/s12879-020-05624-0
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1186/s12879-020-05624-0
- https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-020-05624-0
- OA Status
- gold
- Cited By
- 8
- References
- 36
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3110526475
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3110526475Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s12879-020-05624-0Digital Object Identifier
- Title
-
Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-11-30Full publication date if available
- Authors
-
Tessa du Toit, Tonya M. Esterhuizen, Nicki Tiffin, Ahmed A. Abulfathi, Helmuth Reuter, Eric DecloedtList of authors in order
- Landing page
-
https://doi.org/10.1186/s12879-020-05624-0Publisher landing page
- PDF URL
-
https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-020-05624-0Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-020-05624-0Direct OA link when available
- Concepts
-
Medicine, Tuberculosis, Incidence (geometry), Internal medicine, Disease, Epidemiology, Medical microbiology, Adalimumab, Relative risk, Confidence interval, Surgery, Immunology, Pathology, Physics, OpticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
8Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 3, 2023: 2, 2022: 3Per-year citation counts (last 5 years)
- References (count)
-
36Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3110526475 |
|---|---|
| doi | https://doi.org/10.1186/s12879-020-05624-0 |
| ids.doi | https://doi.org/10.1186/s12879-020-05624-0 |
| ids.mag | 3110526475 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33256634 |
| ids.openalex | https://openalex.org/W3110526475 |
| fwci | 0.14343443 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000293 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adolescent |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000328 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Adult |
| mesh[2].qualifier_ui | Q000009 |
| mesh[2].descriptor_ui | D061067 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | adverse effects |
| mesh[2].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[3].qualifier_ui | Q000494 |
| mesh[3].descriptor_ui | D061067 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | pharmacology |
| mesh[3].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[4].qualifier_ui | Q000009 |
| mesh[4].descriptor_ui | D018501 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | adverse effects |
| mesh[4].descriptor_name | Antirheumatic Agents |
| mesh[5].qualifier_ui | Q000494 |
| mesh[5].descriptor_ui | D018501 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | pharmacology |
| mesh[5].descriptor_name | Antirheumatic Agents |
| mesh[6].qualifier_ui | Q000009 |
| mesh[6].descriptor_ui | D001688 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | adverse effects |
| mesh[6].descriptor_name | Biological Products |
| mesh[7].qualifier_ui | Q000494 |
| mesh[7].descriptor_ui | D001688 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | pharmacology |
| mesh[7].descriptor_name | Biological Products |
| mesh[8].qualifier_ui | Q000009 |
| mesh[8].descriptor_ui | D001691 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | adverse effects |
| mesh[8].descriptor_name | Biological Therapy |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D005260 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Female |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D005500 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Follow-Up Studies |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D015994 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Incidence |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D008297 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Male |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D008875 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Middle Aged |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D009169 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Mycobacterium tuberculosis |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D012189 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Retrospective Studies |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D012307 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Risk Factors |
| mesh[18].qualifier_ui | Q000453 |
| mesh[18].descriptor_ui | D013019 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | epidemiology |
| mesh[18].descriptor_name | South Africa |
| mesh[19].qualifier_ui | Q000453 |
| mesh[19].descriptor_ui | D014376 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | epidemiology |
| mesh[19].descriptor_name | Tuberculosis |
| mesh[20].qualifier_ui | Q000382 |
| mesh[20].descriptor_ui | D014376 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | microbiology |
| mesh[20].descriptor_name | Tuberculosis |
| mesh[21].qualifier_ui | Q000037 |
| mesh[21].descriptor_ui | D014409 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | antagonists & inhibitors |
| mesh[21].descriptor_name | Tumor Necrosis Factor-alpha |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D055815 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Young Adult |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000293 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Adolescent |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D000328 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Adult |
| mesh[25].qualifier_ui | Q000009 |
| mesh[25].descriptor_ui | D061067 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | adverse effects |
| mesh[25].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[26].qualifier_ui | Q000494 |
| mesh[26].descriptor_ui | D061067 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | pharmacology |
| mesh[26].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[27].qualifier_ui | Q000009 |
| mesh[27].descriptor_ui | D018501 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | adverse effects |
| mesh[27].descriptor_name | Antirheumatic Agents |
| mesh[28].qualifier_ui | Q000494 |
| mesh[28].descriptor_ui | D018501 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | pharmacology |
| mesh[28].descriptor_name | Antirheumatic Agents |
| mesh[29].qualifier_ui | Q000009 |
| mesh[29].descriptor_ui | D001688 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | adverse effects |
| mesh[29].descriptor_name | Biological Products |
| mesh[30].qualifier_ui | Q000494 |
| mesh[30].descriptor_ui | D001688 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | pharmacology |
| mesh[30].descriptor_name | Biological Products |
| mesh[31].qualifier_ui | Q000009 |
| mesh[31].descriptor_ui | D001691 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | adverse effects |
| mesh[31].descriptor_name | Biological Therapy |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D005260 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Female |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D005500 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Follow-Up Studies |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D006801 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Humans |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D015994 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Incidence |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D008297 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Male |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D008875 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Middle Aged |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D009169 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Mycobacterium tuberculosis |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D012189 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Retrospective Studies |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D012307 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Risk Factors |
| mesh[41].qualifier_ui | Q000453 |
| mesh[41].descriptor_ui | D013019 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | epidemiology |
| mesh[41].descriptor_name | South Africa |
| mesh[42].qualifier_ui | Q000453 |
| mesh[42].descriptor_ui | D014376 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | epidemiology |
| mesh[42].descriptor_name | Tuberculosis |
| mesh[43].qualifier_ui | Q000382 |
| mesh[43].descriptor_ui | D014376 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | microbiology |
| mesh[43].descriptor_name | Tuberculosis |
| mesh[44].qualifier_ui | Q000037 |
| mesh[44].descriptor_ui | D014409 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | antagonists & inhibitors |
| mesh[44].descriptor_name | Tumor Necrosis Factor-alpha |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D055815 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Young Adult |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D000293 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Adolescent |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D000328 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Adult |
| mesh[48].qualifier_ui | Q000009 |
| mesh[48].descriptor_ui | D061067 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | adverse effects |
| mesh[48].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[49].qualifier_ui | Q000494 |
| mesh[49].descriptor_ui | D061067 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | pharmacology |
| mesh[49].descriptor_name | Antibodies, Monoclonal, Humanized |
| type | article |
| title | Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018 |
| biblio.issue | 1 |
| biblio.volume | 20 |
| biblio.last_page | 900 |
| biblio.first_page | 900 |
| topics[0].id | https://openalex.org/T10038 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | Tuberculosis Research and Epidemiology |
| topics[1].id | https://openalex.org/T10200 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9968000054359436 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2745 |
| topics[1].subfield.display_name | Rheumatology |
| topics[1].display_name | Rheumatoid Arthritis Research and Therapies |
| topics[2].id | https://openalex.org/T11381 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9937999844551086 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Infectious Diseases and Tuberculosis |
| is_xpac | False |
| apc_list.value | 1690 |
| apc_list.currency | GBP |
| apc_list.value_usd | 2072 |
| apc_paid.value | 1690 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 2072 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8880561590194702 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2781069245 |
| concepts[1].level | 2 |
| concepts[1].score | 0.8446054458618164 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q12204 |
| concepts[1].display_name | Tuberculosis |
| concepts[2].id | https://openalex.org/C61511704 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6767398715019226 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1671857 |
| concepts[2].display_name | Incidence (geometry) |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6327407956123352 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C2779134260 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5092428922653198 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[4].display_name | Disease |
| concepts[5].id | https://openalex.org/C107130276 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4848884046077728 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q133805 |
| concepts[5].display_name | Epidemiology |
| concepts[6].id | https://openalex.org/C190139176 |
| concepts[6].level | 2 |
| concepts[6].score | 0.45754027366638184 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q598976 |
| concepts[6].display_name | Medical microbiology |
| concepts[7].id | https://openalex.org/C2780132546 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4392596483230591 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q348260 |
| concepts[7].display_name | Adalimumab |
| concepts[8].id | https://openalex.org/C82789193 |
| concepts[8].level | 3 |
| concepts[8].score | 0.41334763169288635 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2142611 |
| concepts[8].display_name | Relative risk |
| concepts[9].id | https://openalex.org/C44249647 |
| concepts[9].level | 2 |
| concepts[9].score | 0.3807124197483063 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[9].display_name | Confidence interval |
| concepts[10].id | https://openalex.org/C141071460 |
| concepts[10].level | 1 |
| concepts[10].score | 0.36686792969703674 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[10].display_name | Surgery |
| concepts[11].id | https://openalex.org/C203014093 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3038211762905121 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[11].display_name | Immunology |
| concepts[12].id | https://openalex.org/C142724271 |
| concepts[12].level | 1 |
| concepts[12].score | 0.15184089541435242 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[12].display_name | Pathology |
| concepts[13].id | https://openalex.org/C121332964 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[13].display_name | Physics |
| concepts[14].id | https://openalex.org/C120665830 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q14620 |
| concepts[14].display_name | Optics |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8880561590194702 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/tuberculosis |
| keywords[1].score | 0.8446054458618164 |
| keywords[1].display_name | Tuberculosis |
| keywords[2].id | https://openalex.org/keywords/incidence |
| keywords[2].score | 0.6767398715019226 |
| keywords[2].display_name | Incidence (geometry) |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.6327407956123352 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/disease |
| keywords[4].score | 0.5092428922653198 |
| keywords[4].display_name | Disease |
| keywords[5].id | https://openalex.org/keywords/epidemiology |
| keywords[5].score | 0.4848884046077728 |
| keywords[5].display_name | Epidemiology |
| keywords[6].id | https://openalex.org/keywords/medical-microbiology |
| keywords[6].score | 0.45754027366638184 |
| keywords[6].display_name | Medical microbiology |
| keywords[7].id | https://openalex.org/keywords/adalimumab |
| keywords[7].score | 0.4392596483230591 |
| keywords[7].display_name | Adalimumab |
| keywords[8].id | https://openalex.org/keywords/relative-risk |
| keywords[8].score | 0.41334763169288635 |
| keywords[8].display_name | Relative risk |
| keywords[9].id | https://openalex.org/keywords/confidence-interval |
| keywords[9].score | 0.3807124197483063 |
| keywords[9].display_name | Confidence interval |
| keywords[10].id | https://openalex.org/keywords/surgery |
| keywords[10].score | 0.36686792969703674 |
| keywords[10].display_name | Surgery |
| keywords[11].id | https://openalex.org/keywords/immunology |
| keywords[11].score | 0.3038211762905121 |
| keywords[11].display_name | Immunology |
| keywords[12].id | https://openalex.org/keywords/pathology |
| keywords[12].score | 0.15184089541435242 |
| keywords[12].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1186/s12879-020-05624-0 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S171015910 |
| locations[0].source.issn | 1471-2334 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1471-2334 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | BMC Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310320256 |
| locations[0].source.host_organization_name | BioMed Central |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320256 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-020-05624-0 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | BMC Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1186/s12879-020-05624-0 |
| locations[1].id | pmid:33256634 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | BMC infectious diseases |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33256634 |
| locations[2].id | pmh:oai:doaj.org/article:c0d7a02bb6724b80a187e08b12c1f66b |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | cc-by-sa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-8 (2020) |
| locations[2].landing_page_url | https://doaj.org/article/c0d7a02bb6724b80a187e08b12c1f66b |
| locations[3].id | pmh:oai:scholar.sun.ac.za:10019.1/110373 |
| locations[3].is_oa | False |
| locations[3].source.id | https://openalex.org/S4306400300 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | SUNScholar (Stellenbosch University) |
| locations[3].source.host_organization | https://openalex.org/I26092322 |
| locations[3].source.host_organization_name | Stellenbosch University |
| locations[3].source.host_organization_lineage | https://openalex.org/I26092322 |
| locations[3].license | |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Journal Article |
| locations[3].license_id | |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | http://hdl.handle.net/10019.1/110373 |
| locations[4].id | pmh:oai:pubmedcentral.nih.gov:7706240 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S2764455111 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | PubMed Central |
| locations[4].source.host_organization | https://openalex.org/I1299303238 |
| locations[4].source.host_organization_name | National Institutes of Health |
| locations[4].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[4].license | other-oa |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | Text |
| locations[4].license_id | https://openalex.org/licenses/other-oa |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | BMC Infect Dis |
| locations[4].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/7706240 |
| locations[5].id | pmh:oai:scholar.sun.ac.za:10019.1/109623 |
| locations[5].is_oa | False |
| locations[5].source.id | https://openalex.org/S4306400300 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | SUNScholar (Stellenbosch University) |
| locations[5].source.host_organization | https://openalex.org/I26092322 |
| locations[5].source.host_organization_name | Stellenbosch University |
| locations[5].source.host_organization_lineage | https://openalex.org/I26092322 |
| locations[5].license | |
| locations[5].pdf_url | |
| locations[5].version | submittedVersion |
| locations[5].raw_type | Article |
| locations[5].license_id | |
| locations[5].is_accepted | False |
| locations[5].is_published | False |
| locations[5].raw_source_name | |
| locations[5].landing_page_url | http://hdl.handle.net/10019.1/109623 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5006364380 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Tessa du Toit |
| authorships[0].countries | ZA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, Republic of South Africa |
| authorships[0].institutions[0].id | https://openalex.org/I26092322 |
| authorships[0].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[0].institutions[0].country_code | ZA |
| authorships[0].institutions[0].display_name | Stellenbosch University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Tessa du Toit |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, Republic of South Africa |
| authorships[1].author.id | https://openalex.org/A5015842195 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-8703-1664 |
| authorships[1].author.display_name | Tonya M. Esterhuizen |
| authorships[1].countries | ZA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa |
| authorships[1].institutions[0].id | https://openalex.org/I26092322 |
| authorships[1].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[1].institutions[0].country_code | ZA |
| authorships[1].institutions[0].display_name | Stellenbosch University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Tonya M. Esterhuizen |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa |
| authorships[2].author.id | https://openalex.org/A5062637825 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-5083-2735 |
| authorships[2].author.display_name | Nicki Tiffin |
| authorships[2].countries | ZA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I157614274 |
| authorships[2].affiliations[0].raw_affiliation_string | Computational Biology Division, Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa |
| authorships[2].institutions[0].id | https://openalex.org/I157614274 |
| authorships[2].institutions[0].ror | https://ror.org/03p74gp79 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I157614274 |
| authorships[2].institutions[0].country_code | ZA |
| authorships[2].institutions[0].display_name | University of Cape Town |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Nicki Tiffin |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Computational Biology Division, Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa |
| authorships[3].author.id | https://openalex.org/A5026807326 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2089-3614 |
| authorships[3].author.display_name | Ahmed A. Abulfathi |
| authorships[3].countries | ZA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, Republic of South Africa |
| authorships[3].institutions[0].id | https://openalex.org/I26092322 |
| authorships[3].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[3].institutions[0].country_code | ZA |
| authorships[3].institutions[0].display_name | Stellenbosch University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Ahmed A. Abulfathi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, Republic of South Africa |
| authorships[4].author.id | https://openalex.org/A5086135229 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-4672-1412 |
| authorships[4].author.display_name | Helmuth Reuter |
| authorships[4].countries | ZA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, Republic of South Africa |
| authorships[4].institutions[0].id | https://openalex.org/I26092322 |
| authorships[4].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[4].institutions[0].country_code | ZA |
| authorships[4].institutions[0].display_name | Stellenbosch University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Helmuth Reuter |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, Republic of South Africa |
| authorships[5].author.id | https://openalex.org/A5089203897 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1815-5150 |
| authorships[5].author.display_name | Eric Decloedt |
| authorships[5].countries | ZA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, Republic of South Africa |
| authorships[5].institutions[0].id | https://openalex.org/I26092322 |
| authorships[5].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[5].institutions[0].country_code | ZA |
| authorships[5].institutions[0].display_name | Stellenbosch University |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Eric H. Decloedt |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, Republic of South Africa |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-020-05624-0 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018 |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10038 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | Tuberculosis Research and Epidemiology |
| related_works | https://openalex.org/W2316822442, https://openalex.org/W2901883939, https://openalex.org/W2563362192, https://openalex.org/W4387900286, https://openalex.org/W3097370318, https://openalex.org/W2405634423, https://openalex.org/W2560260758, https://openalex.org/W3158974035, https://openalex.org/W2163808629, https://openalex.org/W2119046820 |
| cited_by_count | 8 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 2 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 3 |
| locations_count | 6 |
| best_oa_location.id | doi:10.1186/s12879-020-05624-0 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S171015910 |
| best_oa_location.source.issn | 1471-2334 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1471-2334 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | BMC Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310320256 |
| best_oa_location.source.host_organization_name | BioMed Central |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-020-05624-0 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | BMC Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s12879-020-05624-0 |
| primary_location.id | doi:10.1186/s12879-020-05624-0 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S171015910 |
| primary_location.source.issn | 1471-2334 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1471-2334 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | BMC Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310320256 |
| primary_location.source.host_organization_name | BioMed Central |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320256 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-020-05624-0 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | BMC Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1186/s12879-020-05624-0 |
| publication_date | 2020-11-30 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W1605845768, https://openalex.org/W2180010286, https://openalex.org/W2612613166, https://openalex.org/W2101470299, https://openalex.org/W2198559016, https://openalex.org/W2493507194, https://openalex.org/W2729911064, https://openalex.org/W2332589616, https://openalex.org/W2620710772, https://openalex.org/W2602321146, https://openalex.org/W2088635512, https://openalex.org/W2767456400, https://openalex.org/W2619473673, https://openalex.org/W2541661601, https://openalex.org/W2805916216, https://openalex.org/W1843871470, https://openalex.org/W2041476564, https://openalex.org/W2070353058, https://openalex.org/W2122316162, https://openalex.org/W2991673750, https://openalex.org/W4980310, https://openalex.org/W2997073705, https://openalex.org/W2748204910, https://openalex.org/W2017447237, https://openalex.org/W2780838299, https://openalex.org/W2560725976, https://openalex.org/W2158575023, https://openalex.org/W2736781643, https://openalex.org/W2565228854, https://openalex.org/W2411662729, https://openalex.org/W2743730445, https://openalex.org/W2769270396, https://openalex.org/W4285719527, https://openalex.org/W3086862208, https://openalex.org/W2115987656, https://openalex.org/W2127438204 |
| referenced_works_count | 36 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 94 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8700000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.58394055 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |